腎臓の老化:研究モデル,介入,開発トレンド
Yongpan An1, Ruixiao Li2, Rui Zhang3
1Department of Urology, Xi'an People's Hospital (Xi'an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi'an, Shaanxi 710199, China; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, Shaanxi, China.
Drug discovery today
|February 15, 2026
まとめ
腎臓の老化は,特に高齢者の場合,損傷と病気につながる. このレビューは,老化による腎臓の変化,老化モデル,そして,よりよい腎臓の健康のために老化を遅らせる戦略を網羅しています.
科学分野:
- ネフロロジーは腎臓科です.
- ゲロントロジーはゲロントロジーの学科です.
- 分子生物学は分子生物学である.
背景:
- 老化した腎臓は損傷を受けやすく,腎臓疾患の危険因子です.
- 高齢者の慢性腎臓病は,世界的な健康上の懸念が高まっています.
- 腎臓の老化の分子および細胞メカニズムを理解するうえでの進歩は極めて重要です.
研究 の 目的:
- 老化中の腎臓の病理学的変化を要約すると.
- 腎老化の疾患モデルを調査する.
- 腎臓の老化を遅らせるための潜在的な戦略を見直す.
主な方法:
- 老化中の腎臓の病理学的変化に関する文献レビュー.
- 腎老化疾患モデルの体系的な調査.
- 腎臓の老化を遅らせるための潜在的な介入の分析.
主要な成果:
- 腎臓の構造と機能における年齢に関連する病理学的変化の詳細な説明.
- 腎臓の老化を研究するための既定および新興モデルの概要.
- 腎臓の老化を緩和するための治療目標と戦略の特定.
結論:
- 腎臓の老化メカニズムを理解することは,年齢に関連する腎臓疾患の予防の鍵です.
- 病気のモデルは,老化と潜在的な介入に関する洞察を提供します.
- 腎臓の老化を遅らせる戦略は,将来の研究と臨床実践のための理論的基礎を提供します.
関連する概念動画
Aging
849
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
849
Pharmacodynamics in Geriatric Patients: Effects of Age
242
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242
The Effect of Aging on Tissues
3.7K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
232
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
232
Mitochondria
20.7K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
20.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
717
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717


